A citation-based method for searching scientific literature

Huiling He, Wei Li, Daniel F Comiskey, Sandya Liyanarachchi, Taina T Nieminen, Yanqiang Wang, Katherine E DeLap, Pamela Brock, Albert de la Chapelle. Thyroid 2020
Times Cited: 15







List of co-cited articles
139 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
201
33

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Lauren G Aoude, Antonia L Pritchard, Carla Daniela Robles-Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael Gartside, Víctor Quesada, Peter Johansson, Jane M Palmer,[...]. J Natl Cancer Inst 2014
102
33

A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer.
Aayushi Srivastava, Beiping Miao, Diamanto Skopelitou, Varun Kumar, Abhishek Kumar, Nagarajan Paramasivam, Elena Bonora, Kari Hemminki, Asta Försti, Obul Reddy Bandapalli. Cancers (Basel) 2020
10
50

Identification of Rare Variants Predisposing to Thyroid Cancer.
Yanqiang Wang, Sandya Liyanarachchi, Katherine E Miller, Taina T Nieminen, Daniel F Comiskey, Wei Li, Pamela Brock, David E Symer, Keiko Akagi, Katherine E DeLap,[...]. Thyroid 2019
23
33

A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
Tremika Le-Shan Wilson, Namita Hattangady, Antonio Marcondes Lerario, Carmen Williams, Erika Koeppe, Shane Quinonez, Jenae Osborne, Kelly B Cha, Tobias Else. Fam Cancer 2017
24
26

Melanoma genetics.
Jazlyn Read, Karin A W Wadt, Nicholas K Hayward. J Med Genet 2016
116
26

Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
Melissa A Richard, Philip J Lupo, Lindsay M Morton, Yutaka A Yasui, Yadav A Sapkota, Michael A Arnold, Geraldine Aubert, Joseph P Neglia, Lucie M Turcotte, Wendy M Leisenring,[...]. PLoS One 2020
14
28

Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
Marco Capezzone, Silvia Cantara, Stefania Marchisotta, Sebastiano Filetti, Maria Margherita De Santi, Benedetta Rossi, Giuseppe Ronga, Cosimo Durante, Furio Pacini. J Clin Endocrinol Metab 2008
63
26

A genome-wide association study yields five novel thyroid cancer risk loci.
Julius Gudmundsson, Gudmar Thorleifsson, Jon K Sigurdsson, Lilja Stefansdottir, Jon G Jonasson, Sigurjon A Gudjonsson, Daniel F Gudbjartsson, Gisli Masson, Hrefna Johannsdottir, Gisli H Halldorsson,[...]. Nat Commun 2017
73
26

Identification, genetic testing, and management of hereditary melanoma.
Sancy A Leachman, Olivia M Lucero, Jone E Sampson, Pamela Cassidy, William Bruno, Paola Queirolo, Paola Ghiorzo. Cancer Metastasis Rev 2017
53
20

POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
221
20

Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.
Thomas P Potjer, Sander Bollen, Anneliese J E M Grimbergen, Remco van Doorn, Nelleke A Gruis, Christi J van Asperen, Frederik J Hes, Nienke van der Stoep. Int J Cancer 2019
26
20


Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1.
Lorenza Pastorino, Virginia Andreotti, Bruna Dalmasso, Irene Vanni, Giulia Ciccarese, Mario Mandalà, Giuseppe Spadola, Maria Antonietta Pizzichetta, Giovanni Ponti, Maria Grazia Tibiletti,[...]. Cancers (Basel) 2020
10
30

Assessing thyroid cancer risk using polygenic risk scores.
Sandya Liyanarachchi, Julius Gudmundsson, Egil Ferkingstad, Huiling He, Jon G Jonasson, Vinicius Tragante, Folkert W Asselbergs, Li Xu, Lambertus A Kiemeney, Romana T Netea-Maier,[...]. Proc Natl Acad Sci U S A 2020
15
20

Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
D E Goldgar, D F Easton, L A Cannon-Albright, M H Skolnick. J Natl Cancer Inst 1994
775
20


Familial nonmedullary thyroid carcinoma.
Haggi Mazeh, Rebecca S Sippel. Thyroid 2013
34
20

Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.
Sudheer Kumar Gara, Li Jia, Maria J Merino, Sunita K Agarwal, Lisa Zhang, Maggie Cam, Dhaval Patel, Electron Kebebew. N Engl J Med 2015
96
20


Familial non-medullary thyroid cancer: unraveling the genetic maze.
Samantha Peiling Yang, Joanne Ngeow. Endocr Relat Cancer 2016
60
20

A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
F Canzian, P Amati, H R Harach, J L Kraimps, F Lesueur, J Barbier, P Levillain, G Romeo, D Bonneau. Am J Hum Genet 1998
183
20

Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.
Julius Gudmundsson, Patrick Sulem, Daniel F Gudbjartsson, Jon G Jonasson, Asgeir Sigurdsson, Jon T Bergthorsson, Huiling He, Thorarinn Blondal, Frank Geller, Margret Jakobsdottir,[...]. Nat Genet 2009
291
20

NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer.
Aida Orois, Sudheer K Gara, Mireia Mora, Irene Halperin, Sandra Martínez, Rocio Alfayate, Electron Kebebew, Josep Oriola. Genes (Basel) 2019
11
27

Discovery of common variants associated with low TSH levels and thyroid cancer risk.
Julius Gudmundsson, Patrick Sulem, Daniel F Gudbjartsson, Jon G Jonasson, Gisli Masson, Huiling He, Aslaug Jonasdottir, Asgeir Sigurdsson, Simon N Stacey, Hrefna Johannsdottir,[...]. Nat Genet 2012
160
20

Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.
Anna Wójcicka, Małgorzata Czetwertyńska, Michał Świerniak, Joanna Długosińska, Monika Maciąg, Agnieszka Czajka, Kinga Dymecka, Anna Kubiak, Adam Kot, Rafał Płoski,[...]. Genes Chromosomes Cancer 2014
41
20

A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Elly S W Ngan, Brian H H Lang, Tingting Liu, Cathy K Y Shum, Man-Ting So, Danny K C Lau, Thomas Y Y Leon, Stacey S Cherny, Sophia Y Tsai, Chung-Yau Lo,[...]. J Natl Cancer Inst 2009
77
20

A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition.
Jerneja Tomsic, Huiling He, Keiko Akagi, Sandya Liyanarachchi, Qun Pan, Blake Bertani, Rebecca Nagy, David E Symer, Benjamin J Blencowe, Albert de la Chapelle. Sci Rep 2015
58
20

Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres.
Silvia Cantara, Serena Capuano, Marco Capezzone, Michele Benigni, Milena Pisu, Stefania Marchisotta, Furio Pacini. Thyroid 2012
14
21

Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.
J D McKay, F Lesueur, L Jonard, A Pastore, J Williamson, L Hoffman, J Burgess, A Duffield, M Papotti, M Stark,[...]. Am J Hum Genet 2001
145
20

Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.
C D Malchoff, M Sarfarazi, B Tendler, F Forouhar, G Whalen, V Joshi, A Arnold, D M Malchoff. J Clin Endocrinol Metab 2000
150
20


SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.
Huiling He, Agnieszka Bronisz, Sandya Liyanarachchi, Rebecca Nagy, Wei Li, Yungui Huang, Keiko Akagi, Motoyasu Saji, Dorota Kula, Anna Wojcicka,[...]. J Clin Endocrinol Metab 2013
57
20

The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.
Jayakrishnan Nandakumar, Caitlin F Bell, Ina Weidenfeld, Arthur J Zaug, Leslie A Leinwand, Thomas R Cech. Nature 2012
215
20


TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends.
Franklin L Zhong, Luis F Z Batista, Adam Freund, Matthew F Pech, Andrew S Venteicher, Steven E Artandi. Cell 2012
195
20


Telomerase activity in human germline and embryonic tissues and cells.
W E Wright, M A Piatyszek, W E Rainey, W Byrd, J W Shay. Dev Genet 1996
969
20

Telomeres shorten during ageing of human fibroblasts.
C B Harley, A B Futcher, C W Greider. Nature 1990
20

Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
Kim Wong, Carla Daniela Robles-Espinoza, David Rodriguez, Saskia S Rudat, Susana Puig, Miriam Potrony, Chi C Wong, James Hewinson, Paula Aguilera, Joan Anton Puig-Butille,[...]. JAMA Dermatol 2019
15
13

The effect on melanoma risk of genes previously associated with telomere length.
Mark M Iles, D Timothy Bishop, John C Taylor, Nicholas K Hayward, Myriam Brossard, Anne E Cust, Alison M Dunning, Jeffrey E Lee, Eric K Moses, Lars A Akslen,[...]. J Natl Cancer Inst 2014
96
13

Structural and functional analysis of the human POT1-TPP1 telomeric complex.
Cory Rice, Prashanth Krishna Shastrula, Andrew V Kossenkov, Robert Hills, Duncan M Baird, Louise C Showe, Tzanko Doukov, Susan Janicki, Emmanuel Skordalakes. Nat Commun 2017
56
13

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.
Oriol Calvete, Paula Martinez, Pablo Garcia-Pavia, Carlos Benitez-Buelga, Beatriz Paumard-Hernández, Victoria Fernandez, Fernando Dominguez, Clara Salas, Nuria Romero-Laorden, Jesus Garcia-Donas,[...]. Nat Commun 2015
86
13

Rare germline variants in known melanoma susceptibility genes in familial melanoma.
Alisa M Goldstein, Yanzi Xiao, Joshua Sampson, Bin Zhu, Melissa Rotunno, Hunter Bennett, Yixuan Wen, Kristine Jones, Aurelie Vogt, Laurie Burdette,[...]. Hum Mol Genet 2017
23
13

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
13


CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
M Betti, A Aspesi, A Biasi, E Casalone, D Ferrante, P Ogliara, L C Gironi, R Giorgione, P Farinelli, F Grosso,[...]. Cancer Lett 2016
47
13

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
Matthew H Law, D Timothy Bishop, Jeffrey E Lee, Myriam Brossard, Nicholas G Martin, Eric K Moses, Fengju Song, Jennifer H Barrett, Rajiv Kumar, Douglas F Easton,[...]. Nat Genet 2015
145
13

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
13

Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.
Efthymia Soura, Philip J Eliades, Kristen Shannon, Alexander J Stratigos, Hensin Tsao. J Am Acad Dermatol 2016
85
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.